| Janssen-Cilag AG - Invokana 300 mg, Filmtabletten | | 62956 | | 02 | | Invokana 300 mg | | Filmtabletten | | A10BK02 | | Canagliflozin | | 29.01.2014 | | |
| | Composition | | canagliflozinum 300 mg ut canagliflozinum hemihydricum, cellulosum microcristallinum, lactosum 117.78 mg, carmellosum natricum conexum corresp. natrium 2.52 mg, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Canagliflozinum | 300 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Canagliflozinum | 300 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Lactosum | 117.78 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 006 | 30 Comprimé(s) | 53.88 | 75.00 | B | LS | Non | | 008 | 100 Comprimé(s) | 179.58 | 211.70 | B | LS | Non |
|
|
